Source:http://linkedlifedata.com/resource/pubmed/id/15673965
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-1-27
|
pubmed:abstractText |
The present paper reviews the pathophysiology and therapeutic strategies in heart failure based on clinical investigations performed in our institute, and also recently reported large-scale double-blind clinical trials for the medical treatments of heart failure. Careful introduction of beta-blocker therapy along with RAAS inhibitors (ACE inhibitor, ARB, and/or aldosterone antagonist) should bring about marked improvement in mortality and morbidity in all subgroups of patients with heart failure.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1345-4676
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
421-5
|
pubmed:dateRevised |
2011-8-1
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
[Back to the future: pathophysiology and therapeutic strategies in heart failure].
|
pubmed:affiliation |
First Department of Internal Medicine, Nippon Medical School, Tokyo 113-8603, Japan. y-seino@nms.ac.jp
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|